The effect of the two drugs propofol-remifentanil and ketofol in electroconvulsive therapy
Phase 3
- Conditions
- Seizure duration.
- Registration Number
- IRCT20160307026950N9
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients candidates receiving electroconvulsive therapy seizures
Patients older than 6 yeras old and younger than 25 years old
Patients with American society of anesthesiology physical status class 1,2 (ASAI,II)
Exclusion Criteria
Severe cardiovascular disease
Severe respiratory disease
Severe kidney disease
Severe Liver disease
drugs Allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seizure duration. Timepoint: After intervention. Method of measurement: In seconds using a chornometer.;Heart rate changes. Timepoint: Before the intervention, 1 , 5, 10 minutes after intervention and After The discharge time of recovery. Method of measurement: Pulse oximetry device.;Mean arterial blood pressure. Timepoint: Before the intervention, 1 , 5, 10 minutes after intervention and After The discharge time of recovery. Method of measurement: Non invasive blood pressure.;Oxygen saturation. Timepoint: Before the intervention, 1 , 5, 10 minutes after intervention and After The discharge time of recovery. Method of measurement: Pulse oximetry device.;Recovery Duration. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with using a chronometer.
- Secondary Outcome Measures
Name Time Method ausea and Vomiting. Timepoint: After end of the seizure. Method of measurement: Questionnaire.;Laryngospasm. Timepoint: After end of the seizure. Method of measurement: Questionnaire.